Last reviewed · How we verify
NCT05246930
Evaluating the Use of a Device Called Impulse Oscillometry in Participants With Vocal Cord Disorders or Asthma
trial testing Impulse Oscillometer in Breathing, Mouth in 43 participants. Completed in 1 December 2024.
1 June 2024
Quick facts
| Lead sponsor | University of Rochester |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 43 |
| Start date | 15 June 2022 |
| Primary completion | 1 June 2024 |
| Estimated completion | 1 December 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Impulse Oscillometer
Conditions studied
- Breathing, Mouth — all drugs for Breathing, Mouth →
- Lung Function Decreased — all drugs for Lung Function Decreased →
- Vocal Cord Dysfunction — all drugs for Vocal Cord Dysfunction →
- Laryngeal Obstruction — all drugs for Laryngeal Obstruction →
Sponsor
University of Rochester
Who can join
18 and older, any sex, with Breathing, Mouth or Lung Function Decreased. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will determine if airway resistance to airflow and pressure, measured by Impulse Oscillometry, is impacted in subjects with vocal cord disorders and whether these measurements are different when compared to subjects with asthma.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05246930
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Impulse Oscillometer
Trials testing the same drug.
- NCT05085795 — Evaluating Deep Breathing in Health Participants Using a Device Called Impulse Oscillometry · completed
Other recruiting trials for Breathing, Mouth
Currently open trials in the same condition.
- NCT06747533 — Impact of Diaphragmatic Breathing Coaching on Deep Inspiration Breath Hold Reproducibility and Organ Protection · NA · active not recruiting
- NCT07411417 — Combined Acupressure Effects on Post-Thoracotomy Pain and Lung Volume · NA · recruiting
- NCT06554353 — Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea · recruiting
- NCT07018128 — Expression of Genes Relating Hypertension and Efficacy of 4-7-8 Breathing Control on Reducing Blood Pressure · NA · recruiting
- NCT05987982 — Mouth Odor on Preventing Pneumonia by Oral Frailty · NA · recruiting
Other University of Rochester trials
Trials by the same sponsor.
- NCT07075965 — Calcium Channel Blocker in Myotonic Dystrophy Type 1 · Phase 1 · not yet recruiting
- NCT07423104 — A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloi · Phase 2 · not yet recruiting
- NCT05744869 — SBAT for Health Equity · NA · not yet recruiting
- NCT06052956 — Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses · Phase 2 · not yet recruiting
- NCT07032636 — Reducing Crises and Suicide Within the Idaho Army National Guard · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05246930 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Rochester
- Last refreshed: 18 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05246930.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing